Kheiron launches AI software for breast cancer screening

By staff writers

March 1, 2019 -- U.K. start-up Kheiron Medical Technologies has launched Mia, its artificial intelligence (AI) software for breast cancer screening.

Mia, short for mammography intelligent assessment, is capable of analyzing the digital mammograms of patients with suspected breast cancer. In a prior clinical validation study, Mia surpassed the standard for single radiologist reporting of breast cancer -- showing that the software may help reduce errors in breast cancer detection, according to the company.

Kheiron received the CE Mark for Mia last year, and it plans to conduct additional clinical trials to evaluate the software's performance and potential impact on breast screening outcomes.

Kheiron gets funding to test deep-learning mammo software
U.K. start-up Kheiron Medical Technologies will be testing its deep-learning breast cancer screening software in the National Health Service as part of...

Copyright © 2019

Last Updated np 3/1/2019 11:50:54 AM